INTERVENTIONAL AND STRUCTURAL CARDIOLOGIST BROADENS HOBART’S SURGICAL ABILITIES Tasmanian born, bred and educated cardiologist
With
Dr Heath Adams,
Interventional and Structural Cardiologist
Director of Structural Intervention, Royal Hobart Hospital &
Visiting Medical Officer (VMO) Cardiologist
Hobart Private Hospital &
Adjunct Senior Researcher
Menzies Institute for Medical Research,
University of Tasmania
PEOPLE IN HEATH CARE | AUSTRALIAN HEATH JOURNAL SEGMENT
Filmed in Hobart | March 2025
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
Dr Adams achieved First Class Honours in MBBS at UTAS in 2009. He achieved a Fellowship of the Royal College of Physicians in Adult Cardiology in 2016 after training appointments in Victoria. In 2019, he was the structural heart fellow at St Thomas’ Hospital, London, a worldwide centre of excellence in TAVI and structural heart procedures. This fellowship was supported by the prestigious Dr MG Ciezar Memorial Scholarship in cardiovascular medicine from the University of Tasmania.
Dr Adams has published over 50 manuscripts and abstracts in peer-reviewed journals and has been involved in authoring educational book chapters on TAVI. His current research involves streamlined TAVI, assessing frailty outcomes post valve intervention and performing large-scale real-world outcomes with new structural heart interventions. Dr Adams is a clinical supervisor for trainee physicians at the Royal Hobart Hospital, is a member of the CSANZ Interventional Council.
Heath is passionate about clinical innovation, research and patient outcomes. In his free time, Heath enjoys bushwalking, running, cycling and trying to better his golf game whilst being a busy father to 3 children under the age of 6.
Source: supplied and supplemented
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
Ready to unleash the potential of the pharmacist health workforce
Last week, Associate Professor Fei Sim the National President of the Pharmaceutical Society of Australia (PSA), the peak body representing 39,000 pharmacists across Australia’s health system, spoke to Australian Health Journal about the release of the Unleashing the Potential of our Health Workforce – Scope of Practice Review. The review and final report sets out to create a clear pathway for health professionals to contribute more to our health system and practice to their full and top of scope.
-
Gaining a better understanding of perimenopause and menopause
Nearly half of women seeking help for menopause symptoms are already experiencing clinically significant distress by the time they ask for support, according to a recent national benchmark report released by Metluma.
The 2026 Australian Menopause Experience Report, based on insights from 1,468 women using Metluma’s UMA40 assessment tool, found 43% triggered at least one clinical red flag at baseline (referral to a doctor within 24-48 hours), with more than one in five presenting with multiple red flags linked to more complex symptom burden.
